Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents

In Her2-positive breast cancer patients, inhibition of epidermal growth factor receptor 2 (ErbB2)-signaling is often combined with chemotherapy and radiotherapy. The risk of cardiac toxicity after anthracyclines and radiotherapy is recognized, but little is known about increased risk when these trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Seemann, Ingar, te Poele, Johannes A. M., Song, Ji-Ying, Hoving, Saske, Russell, Nicola S., Stewart, Fiona A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824562/
https://www.ncbi.nlm.nih.gov/pubmed/24091769
http://dx.doi.org/10.1007/s10549-013-2707-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824562/
https://www.ncbi.nlm.nih.gov/pubmed/24091769
http://dx.doi.org/10.1007/s10549-013-2707-7

Ejemplares similares